Physiologic Approach for Non-LM Bifurcation Lesions
All Bifurcation PCI
Statistical and clinical interpretation of the "PROTECTED-TAVR" trial and my take-home messages
Game of Thrones, TAVR vs. SAVR
My 30 Years Story - Caring for Patients with Symptomatic Vascular Disease
EVAR, TEVAR, Peripheral
The MitraClip Shows Promising Results in 5-Year COAPT Trial for Heart Failure Patients
Mitral & Tricuspid Valve Therapy
Optimal MSA for LM Crush Technique: New Criteria Any Difference in Any 2 Stent Technique?
Left Main & Multi-Vessel (Practice Changes after ISCHEMIA)
My Approach to Multi-Vessel Disease Insight from ISCHEMIA Study
Left Main & Multi-Vessel (Concept Changes After ISCHEMIA)
Contemporary Trends in Aortic Stenosis Management - Legend's Perspective
Opening of TCTAP 2023 & Keynote Lectures
Catheter-Based Strategies to Treat Tricuspid Valve Disease
Mitral & Tricuspid Valve Therapy
Insight from All Data of Left Main Revascularization (MAINCOMPARE, SYNTAX, PRECOMBAT, NOBLE, EXCEL)
Left Main & Multi-Vessel (Concept Changes After ISCHEMIA)
P2Y12 Inhibitor or Asprin for Long-term Antiplatelet Management
All About New Data of Antithrombotics
State-of-the-Art Technique for Transcatheter Closure of Paravalvular Leaks
Mitral & Tricuspid Valve Intervention
Radiation Management for Complex Percutaneous Coronary Intervention
Complex PCI - Calcification, Very Long Lesion
Great Debate on MVD 2023: Medical Therapy is Enough vs. Surgery is Still Standard
Left Main & Multi-Vessel (Concept Changes After ISCHEMIA)
The 20th Anniversary of TAVR Ceremony - From Concept to Human Application
Game of Thrones, TAVR vs. SAVR
10-Year Extended Follow-up of BEST Trial
Late-Breaking Clinical Trials 2023 in Asia-Pacific
Routine Functional Testing or Standard Care in High-Risk Patients after PCI
[Published in NEJM] Late-Breaking Clinical Trials 2023 in Asia-Pacific
PREVENT Trial
Future Perspective on Ongoing Trials from AMC
OCTIVUS Trial
Future Perspective on Ongoing Trials from AMC
30 Years History of FFR: From the Concept to Current Status - Legend's Perspective
Opening of TCTAP 2023 & Key Note Lectures
Upfront 2-Stent; New Concept in LM Bifurcation PCI
All Bifurcation PCI
How Can We Improve Reperfussion Therapy in AMI
Acute Coronary Syndrome
Left Main Revascularization; Consensus and Gaps in 2023
LM & Multi-Vessel Diseases and Bifurcation & CTO After ISCHEMIA Study